The U.S. Supreme Court on Monday asked the solicitor general, the federal government’s top Supreme Court lawyer, to submit an opinion on whether the justices should hear Bayer’s challenge to a $1.2 million jury verdict that found its Roundup weedkiller caused a man’s cancer. The request pauses a decision on the company’s petition and effectively draws the Trump administration into the long-running dispute over glyphosate, the herbicide’s active ingredient. Bayer, which acquired Monsanto and its Roundup brand in 2018, argues that federal law pre-empts state-level failure-to-warn claims because the Environmental Protection Agency continues to deem glyphosate non-carcinogenic and bars cancer warnings on the product’s label. A Supreme Court review could shape the fate of tens of thousands of similar lawsuits that together threaten the German group with potential liabilities running into the billions. Chief Executive Officer Bill Anderson called the court’s request for government input “encouraging,” though the referral extends the timeline for any definitive ruling. Analysts expect the solicitor general to take several months to respond, meaning the justices are unlikely to decide whether to accept the case before late 2025 or early 2026.
The U.S. Supreme Court asked the U.S. solicitor general to weigh in on Monsanto's petition challenging a $1.2 million jury award given to a man who claimed that the company's Roundup weedicide caused his cancer. https://t.co/W3lBG53S0y
Die Entscheidung über die Annahme eines wichtigen Glyphosat-Falls wird in Washington erst einmal vertagt. Bayer-Chef Bill Anderson wertet das trotzdem als „ermutigend“. https://t.co/4yhDwKbaUd
Bayer said on Monday that the U.S. Supreme Court had asked the solicitor general for an opinion in the Durnell case, as the German company seeks clarity from the top U.S. court in litigation related to its weedkiller glyphosate. https://t.co/wyauPloIxe